The South American giant ant, Dinoponera quadriceps (Hymenoptera, Formicidae, Ponerinae), produces proteinaceous venom that has antinociceptive, neuroprotective and antimicrobial effects, thereby supporting the popular use of these ants to treat asthma, rheumatism, earache and back pain. Anticoagulant activity is another biological property that has been shown for the venom of other hymenopteran species, like wasps. The aim of this study was to assess the anti-inflammatory, anticoagulant and antiplatelet properties of D. quadriceps venom (DqV). DqV anti-inflammatory activity was assessed by intravenous administration in Swiss mice in the models of paw edema and peritonitis. In vitro, DqV was assessed in coagulation (activated partial thromboplastin time) and platelet aggregation tests. DqV inhibited (27–33%) the edema elicited by carrageenan and the leucocyte migration (43%) elicited by zymosan. DqV decreased by 57% and 42%, respectively, the content of malondialdehyde and nitrite in the peritoneal fluid. DqV prolonged (1.8x) the clotting time and decreased (27%) the platelet aggregation induced by adenosine diphosphate. The crude venom of D. quadriceps presents an anti-inflammatory effect in mice and in vitro anticoagulant and antiplatelet effects.
(a) PaivaR.V.S., BrandãoC.R.F. (1995) Nests, worker population, and reproductive status of workers, in the giant queenless ponerine ant Dinoponera Roger (Hymenoptera: Formicidae). Ethology Ecology & Evolution, 7, 297–312;(b) Vasconcellos A, Santana GG, Souza AK. (2006) Nest spacing and architecture, and swarming of males of Dinoponera quadriceps (Hymenoptera, Formicidae) in a remnant of the Atlantic forest in Northeast Brazil. Brazilian Journal of Biology, 64, 357–362.
2.
(a) BuschingerA., MaschwitzU. (1984) Defensive behavior and defensive mechanisms in ants. In: Defensive mechanisms in social insects.HermannH.R. (Ed), Praeger, New York; (b) Schmidt JO. (1986) Chemistry, pharmacology, and chemical ecology of ants venoms. In: Venom of the Hymenoptera. Piek T. (Ed), Academic Press, New York.
3.
(a) Costa NetoE.M., Ramos-ElorduyJ., MorenoJ.M.P. (2006) Los insectos medicinales de Brasil: primeiros resultados. Boletín Sociedad Entomológica Aragonesa, 38, 395–414;(b) Alves RRN, Rosa IL. (2007) Zootherapy goes to town: the use of animal-based remedies in urban areas of NE and N Brazil. Journal of Ethnopharmacology, 113, 541–555; (c) Costa Neto EM. (2011) A zooterapia popular no Estado da Bahia: registro de novas espécies animais utilizadas como recursos medicinais. Ciência & Saúde Coletiva, 16, 1639–1650.
4.
SousaP.L., QuinetY., PonteE.L., ValeJ.F., TorresA.F.C., PereiraM.G., AssreuyA.M.S. (2012) Venom's antinociceptive property in the primitive ant Dinoponera quadriceps. Journal of Ethnopharmacology, 144, 213–216.
5.
(a) ColognaC.T., dos Santos CardosoJ., JourdanE., DegueldreM., UpertG., GillesN., Trovatti UetanabaroA.P., Costa NetoE.M., ThonartP., de PauwE., QuintonL. (2013) Peptidomic comparison and characterization of the major components of the venom of the giant ant Dinoponera quadriceps collected in four different areas of Brazil. Journal of Proteomics, 94, 413–422;(b) Lima DB, Torres AF, Mello CP, de Menezes RR, Sampaio TL, Canuto JA, da Silva JJ, Freire VN, Quinet YP, Havt A, Monteiro HS, Nogueira NA, Martins AM. (2014) Antimicrobial effect of Dinoponera quadriceps (Hymenoptera: Formicidae) venom against Staphylococcus aureus strains. Journal of Applied Microbiology, 117, 390–396.
6.
LopesK.S., RiosE.R.V., LimaC.N.C., LinharesM.I., TorresA.F.C., HavtA., QuinetY.P., FontelesM.M.F., MartinsA.M.C. (2013) The effects of the Brazilian ant Dinoponera quadriceps venom on chemically induced seizure models. Neurochemistry International, 63, 141–145.
7.
(a) HansonJ.M., MorleyJ., Soria-HerreraC. (1974) Anti-inflammatory property of 401 (mcdpeptide), a peptide from the venom of the bee Apis mellifera (L.). British Journal of Pharmacology, 50, 383–392;(b) Dkhil MA, Abdel-Baki AS, Al-Quraishi S, Al-Khalifa M. (2010) Anti-inflammatory activity of the venom from samsum ants Pachycondyla sennaarensis. African Journal of Pharmacy and Pharmacology, 4, 115–118; (c) Merlo LA, Bastos LFS, Gondin AM, Rocha LTS, Nascimento EB, Jr., Paiva ALL, Moraes-Santos T, Zumpano AAC, Bastos EMAF, Heneine LGD, Coelho MM. (2011) Effects induced by Apis mellifera venom and its components in experimental models of nociceptive and inflammatory pain. Toxicon, 57, 764–771.
8.
(a) HaimB., RimonA., IshayJ.S., RimonS. (1999) Purification, characterization and anticoagulant activity of a proteolytic enzyme from Vespa orientalis venom. Toxicon, 37, 825–829; (b) Hana J, You D, Xu X, Han W, Lu Y, Lai R, Meng Q. (2008) An anticoagulant serine protease from the wasp venom of Vespa magnifica. Toxicon, 51, 914-922.
9.
VinegarR., SchreiberW., HugoR. (1969) Biphasic development of carrageenan oedema in rats. Journal of Pharmacology and Experimental Therapeutics, 166, 96–103.
10.
IanaroA., O'DonnellC.A., Di RosaM., LiewF.Y. (1994) A nitric oxide synthase inhibitor reduces inflammation, downregulates inflammatory cytokines and enhances interleukin-10 production in carrageenan-induced oedema in mice. Immunology, 82, 370–375.
11.
RaoT.S., CurrieJ.L., ShafferA.F., IsaksonP.C. (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. Journal of Pharmacology and Experimental Therapeutics, 269, 917–925.
12.
AyalaA., MuñozM.F., ArgüellesS. (2014) Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. In Oxidative Medicine and Cellular Longevity.Hindawi Publishing Corporation, ID 360438 (31 pages).
13.
YaoV., McCauleyR., CooperD., PlatellC., HallJ.C. (2004) Zymosan induces nitric oxide production by peritoneal mesothelial cells. ANZ Journal of Surgery, 74, 266–269.
14.
YangaM.J., LinbW-Y, LuaK-H, TuW-C. (2011) Evaluating antioxidative activities of amino acid substitutions on mastoparan-B. Peptides, 32, 2037–2043.
15.
ChenD.M., LeeP.T., ChouK.J., FangH.C., ChungH.M., ChenD.M., ChangL.K. (2004) Descending aortic thrombosis and cerebral infarction after massive wasp stings. American Journal of Medicine, 116, 567–569.
16.
(a) YangaH., XuX., MaD., ZhangK., LaiR. (2008) A phospholipase A1 platelet activator from the wasp venom of Vespa magnifica (Smith). Toxicon, 51, 289–296;(b) Ozaki Y, Matsumoto Y, Yatomi Y, Higashihara M, Kariya T, Kume S. (1990) Mastoparan, a wasp venom, activates platelets via pertussis toxin-sensitive GTP-binding proteins. Biochemical and Biophysical Research Communications, 170, 779–785.
17.
SouzaG.E., FerreiraS.H. (1985) Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents and Actions, 17, 1–5.
18.
HuongN.T., MatsumotoK., KasaR., YamasakiK., WatanebeH. (1998) In vitro antioxidant activity of Vietnamese ginseng saponin and its components. Biological & Pharmaceutical Bulletin, 21, 978–981.
19.
GreenL.C., TannenbaumS.R., GoldmanP. (1981) Nitrate synthesis in the germfree and conventional rat. Science, 212, 56–58.
20.
BornG.V.R., CrossM.J. (1963) The aggregation of blood platelets. Journal of Physiology, 168, 178–195.
